---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-011038"
form_type: "8-K"
ticker: "QCLS"
cik: "0001321834"
company_name: "Q/C TECHNOLOGIES, INC."
filed_at: "2023-04-05T23:59:59+00:00"
generated_at: "2026-06-17T05:44:07.539216+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# MyMD Pharmaceuticals grants 750,000 stock options to President and CMO Chris Chapman

## Summary
- Grant of options to purchase 750,000 shares at $1.55 per share to Dr. Chris Chapman, President and CMO.
- Options vest in three equal annual installments starting April 4, 2023.
- Options expire on fifth anniversary of grant date (April 4, 2028).
- Grant approved by compensation committee on April 4, 2023.

## SEC filing metadata
- accession: 0001493152-23-011038
- form_type: 8-K
- ticker: QCLS
- cik: 0001321834
- company_name: Q/C TECHNOLOGIES, INC.
- filed_at: 2023-04-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1321834/000149315223011038/0001493152-23-011038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1321834/000149315223011038/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-011038
- JSON: https://secwatch.observer/filing/0001493152-23-011038.json
- Plain text: https://secwatch.observer/filing/0001493152-23-011038.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.